Showing results (111-120 of 2,285) with videos related to

Sort By:
Pageof 229
World Journal of Hepatology|September 23, 2021
Clostridioides difficile infection in liver cirrhosis patients: A population-based study in United StatesSyeda Sahra, Mohammad Abureesh, Shivantha Amarnath, et al.
World Journal of Hepatology|September 23, 2021
Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysisTanat Yongpisarn, Chanattha Thimphitthaya, Passisd Laoveeravat, et al.
World Journal of Hepatology|January 24, 2022
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersStefano Mazza, Sara Soro, Maria Chiara Verga, et al.
World Journal of Hepatology|January 24, 2022
Liver manifestations and complications in inflammatory bowel disease: A reviewRui Gaspar, Catarina Castelo Branco, Guilherme Macedo
World Journal of Hepatology|January 24, 2022
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?Roberta Forlano, Benjamin H Mullish, Ameet Dhar, et al.
World Journal of Hepatology|November 16, 2023
Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysisNils Picker, May Hagiwara, Severin Baumann, et al.
World Journal of Hepatology|November 16, 2023
Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stressZhen Li, Jun-Feng Zhu, Hao Ouyang
World Journal of Hepatology|October 30, 2023
Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasmsShubhrat Purwar, Anam Fatima, Himashree Bhattacharyya, et al.
World Journal of Hepatology|October 30, 2023
Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tabletYun-Kai Dai, Hai-Na Fan, Kai Huang, et al.
World Journal of Hepatology|September 13, 2023
Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factorsXin-Juan Huang, Man Yin, Bing-Qian Zhou, et al.
Pageof 229